Phase 2B Study of the Safety and Efficacy of [ 123 I]-BMIPP for Identification of Ischemic Myocardium Using SPECT in Adults Admitted to the ED for Evaluation.
Study funded by Molecular Insight Pharmaceuticals. All investigators
![Phase 2B Study of the Safety and Efficacy of [ 123 I]-BMIPP for Identification of Ischemic Myocardium Using SPECT in Adults Admitted to the ED for Evaluation.](https://static.fdocuments.us/doc/330x215/56649eca5503460f94bd86c0/phase-2b-study-of-the-safety-and-efficacy-of-123-i-bmipp-for-identification.jpg)
